Neuroprotective Effect of Exogenous Galectin-1 in Status Epilepticus

Mol Neurobiol. 2022 Dec;59(12):7354-7369. doi: 10.1007/s12035-022-03038-4. Epub 2022 Sep 29.

Abstract

Intrahippocampal pilocarpine microinjection (H-PILO) induces status epilepticus (SE) that can lead to spontaneous recurrent seizures (SRS) and neurodegeneration in rodents. Studies using animal models have indicated that lectins mediate a variety of biological activities with neuronal benefits, especially galectin-1 (GAL-1), which has been identified as an effective neuroprotective compound. GAL-1 is associated with the regulation of cell adhesion, proliferation, programmed cell death, and immune responses, as well as attenuating neuroinflammation. Here, we administrated GAL-1 to Wistar rats and evaluated the severity of the SE, neurodegenerative and inflammatory patterns in the hippocampal formation. Administration of GAL-1 caused a reduction in the number of class 2 and 4 seizures, indicating a decrease in seizure severity. Furthermore, we observed a reduction in inflammation and neurodegeneration 24 h and 15 days after SE. Overall, these results suggest that GAL-1 has a neuroprotective effect in the early stage of epileptogenesis and provides new insights into the roles of exogenous lectins in temporal lobe epilepsy (TLE).

Keywords: Epilepsy; Epileptogenesis; Lectins; Temporal lobe epilepsy.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Epilepsy, Temporal Lobe* / drug therapy
  • Epilepsy, Temporal Lobe* / metabolism
  • Galectin 1 / metabolism
  • Galectin 1 / pharmacology
  • Galectin 1 / therapeutic use
  • Hippocampus / metabolism
  • Neuroprotective Agents* / metabolism
  • Neuroprotective Agents* / pharmacology
  • Neuroprotective Agents* / therapeutic use
  • Pilocarpine
  • Rats
  • Rats, Wistar
  • Seizures / metabolism
  • Status Epilepticus* / drug therapy
  • Status Epilepticus* / metabolism

Substances

  • Neuroprotective Agents
  • Galectin 1
  • 1-nitrohydroxyphenyl-N-benzoylalanine
  • Pilocarpine